Ultima Genomics Collaborates with Genome Insight
Monday, April 10, 2023
Ultima Genomics and Genome Insight have signed an agreement to collaborate to bring affordable whole genome sequencing solutions to cancer patients.
As part of the agreement, Genome Insight will join the early access programme for Ultima’s high-throughput NGS instrument platform, the UG 100TM, and develop an optimised version of its whole genome bioinformatics solution for Ultima’s sequencing technology. The combination of Genome Insight’s proprietary bioinformatics with Ultima’s low-cost sequencing will make whole genome sequencing an affordable reality for cancer patients.
This partnership with Ultima will bring affordable whole genome sequencing to cancer patients. The ability to analyse the entire genome at a low cost is a game-changer in cancer treatment. This collaboration is an important step towards the vision of using whole genome sequencing to improve patient outcomes.
